U.S. Wealth WatcherCelebrating Political Fortunes
‹ Lobbying

Association For Accessible Medicines

DC · 17 filings, 2025

File · Money Read

What the money shows

Association FOR Accessible Medicines reported $3.1M in federal lobbying for 2025 across 17 filings. The filings name 5 lobbying firms, led by Squire Patton BOGGS and FOLEY & Lardner. The filing text lists 8 issue areas.

Sources: Senate LDA · FEC

Lobbying spend · 2025
$3.1M
to shape legislation
About the organization

The Association for Accessible Medicines (AAM), Washington, D.C., is a trade association representing the manufacturers and distributors of generic prescription drugs, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the U.S. generic drug industry. As the primary lobby for makers of generic drugs, AAM's stated mission is to advocate for public policies that facilitate timely access to lower-cost, FDA-approved generic and biosimilar medicines by consumers and patients. Over the 10-year period 2008 through 2018, the use of generic drugs generated $2 trillion in U.S. healthcare savings. via Wikipedia ↗

1Lobbies on

Its filings list: Trade (domestic/foreign) · Pharmacy · Copyright/Patent/Trademark · Health Issues · Manufacturing · Labor Issues/Antitrust/Workplace · Medicare/Medicaid · Budget/Appropriations

2Through these firms · 5

SQUIRE PATTON BOGGSFOLEY & LARDNER LLPTHE GIBSON GROUP, LLCASSOCIATION FOR ACCESSIBLE MEDICINESRUBIN, TURNBULL & ASSOCIATES

3Bills moving in its lanes

No bill names this company outright; these are recent bills in the sectors it lobbies.